Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Use of minimal extracorporeal circulation circuit for left ventricular assist device implantation..
ASAIO J. 57(6), 547-9.
(2011). Endovascular repair of an internal mammary artery to pulmonary artery acquired fistula..
J Card Surg. 25(6), 666-8.
(2010). Modular minimally invasive extracorporeal circulation systems; can they become the standard practice for performing cardiac surgery?.
Perfusion. 30(3), 195-200.
(2015). Use of minimized extracorporeal circulation system in noncoronary and valve cardiac surgical procedures-a case series..
Artif Organs. 35(10), 960-3.
(2011). Haematological effects of minimized compared to conventional extracorporeal circulation after coronary revascularization procedures..
Perfusion. 25(4), 197-203.
(2010). Quantification of Operational Learning in Minimal Invasive Extracorporeal Circulation..
Artif Organs. 41(7), 628-636.
(2017). Stem cells transplantation combined with long-term mechanical circulatory support enhances myocardial viability in end-stage ischemic cardiomyopathy..
Int J Cardiol. 155(3), e51-3.
(2012). Neurocognitive outcome after coronary artery bypass surgery using minimal versus conventional extracorporeal circulation: a randomised controlled pilot study..
Heart. 97(13), 1082-8.
(2011). Enhanced recovery after elective coronary revascularization surgery with minimal versus conventional extracorporeal circulation: a prospective randomized study..
J Cardiothorac Vasc Anesth. 27(5), 859-64.
(2013). Minimally invasive extracorporeal circulation improves quality of life after coronary artery bypass grafting..
Eur J Cardiothorac Surg. 50(6), 1196-1203.
(2016). Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial..
J Clin Endocrinol Metab. 98(8), 3206-12.
(2013). Selenomethionine treatment in patients with autoimmune thyroiditis: a prospective, quasi-randomised trial..
Int J Clin Pract. 66(4), 378-83.
(2012). Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment..
Expert Opin Ther Targets. 19(3), 299-306.
(2015). Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial..
Horm Metab Res. 40(4), 281-5.
(2008). Coincidence of severe primary hyperparathyroidism and primary hypothyroidism in a postmenopausal woman with low bone mass--initial conservative management..
J Musculoskelet Neuronal Interact. 11(1), 77-80.
(2011). Long-term effects of thyroid fine-needle biopsy on the thyroid-related biochemical parameters..
Int J Clin Pract. 66(6), 602-9.
(2012). Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment..
Horm Metab Res. 46(2), 145-9.
(2014). Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide..
Horm Metab Res. 41(7), 559-62.
(2009). Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment..
Osteoporos Int. 24(7), 2127-32.
(2013). Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-kappaB ligand levels in women with established osteoporosis treated with teriparatide..
Eur J Endocrinol. 158(3), 411-5.
(2008).
(2017). Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls..
Horm Metab Res. 51(2), 112-119.
(2019). Denosumab versus zoledronic acid in patients previously treated with zoledronic acid..
Osteoporos Int. 26(10), 2521-7.
(2015). Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis..
Endocr J. 55(3), 613-6.
(2008). The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass..
Clin Endocrinol (Oxf). 77(6), 816-22.
(2012).